Microsure

Microsure

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12.5M

Overview

Microsure is a pioneering private medical robotics company based in Eindhoven, Netherlands, focused on the microsurgery market. Its core technology is the MUSA robotic system, which scales and filters a surgeon's hand movements, allowing for superhuman precision in procedures on sub-millimeter anatomical structures like lymph vessels and nerves. The company has progressed through clinical studies with its MUSA-2 system and is now commercializing the next-generation MUSA-3. Microsure's value proposition centers on expanding the pool of surgeons capable of performing ultra-precise microsurgery and improving surgical outcomes for patients with complex reconstructive needs.

Reconstructive SurgeryLymphedemaNerve Repair

Technology Platform

MUSA robotic microsurgery platform featuring tremor filtration, motion scaling, and an open architecture for use with standard microsurgical instruments.

Funding History

2
Total raised:$12.5M
Series A$10M
Seed$2.5M

Opportunities

The company addresses a high-value, underserved niche in surgical robotics for supermicrosurgery.
Demographic trends and improved cancer survival rates are increasing the patient population for complex reconstructive procedures, driving long-term demand for precision-enabling tools.

Risk Factors

Key risks include slower-than-expected adoption by a conservative surgeon base, challenges in demonstrating cost-effectiveness to hospital purchasers, potential future competition from larger medical robotics firms, and execution risks in global regulatory strategy and commercialization.

Competitive Landscape

Microsure operates in a nascent segment with few direct competitors. It differentiates itself through its focus on sub-millimeter precision and an open instrument platform. Indirect competition comes from manual microsurgery and potential future entries from giants like Intuitive Surgical or Medtronic into the microsurgery space.